MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH)

CUSIP: 57060U217

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / PHARMACEUTICAL
Total 13F shares
3,444,069
Share change
+48,814
Total reported value
$224,933,532
Price per share
$65.31
Number of holders
57
Value change
+$3,442,589
Number of buys
18
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 57060U217?
CUSIP 57060U217 identifies PPH - MARKET VECTORS ETF TR - PHARMACEUTICAL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) as of Q4 2015

As of 31 Dec 2015, MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,444,069 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, Migdal Insurance & Financial Holdings Ltd., MORGAN STANLEY, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, Clal Insurance Enterprises Holdings Ltd, HOKANSON ASSOCIATES, INC., CITIGROUP INC, STUYVESANT CAPITAL MANAGEMENT, and LPL Financial LLC. This page lists 57 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.